Home › Cardiomyopathy › NCT02432092

Pediatric Cardiomyopathy Mutation Analysis

Who can join

All ages · All sexes

Inclusion Criteria:

* Subjects with cardiomyopathy
* Family members of subjects with cardiomyopathy

Exclusion Criteria:

* Subjects without cardiomyopathy
* Family members of subjects without cardiomyopathy

About the study

The goal of this protocol is to obtain information from individuals with cardiomyopathy and from their families in order to elucidate the molecular genetics of this disorder. This will provide the basis for future genetic counseling as well as contribute to elucidating the biology of normal and abnormal cardiac function.

Sponsor: Indiana University · Participants: 300 · Started: 2014-04

Contact the study team

• Sarah Murphy, MPH · Phone: (317) 278-3026
• Stephanie Ware, MD, PhD · Phone: (317) 278-2807

Official record on ClinicalTrials.gov — NCT02432092

Locations in the U.S.

Conditions

• Cardiomyopathy
• Dilated Cardiomyopathy
• Hypertrophic Cardiomyopathy
• Arrhythmogenic Right Ventricular Dysplasia
• Cardiovascular Disease
• Heart Diseases
• Heart Failure

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.